文献速递肥胖与代谢综合征糖尿病

脂肪组织及循环CCL18水平与女性代谢危险因素相关

Adipose and Circulating CCL18 Levels Associate With Metabolic Risk Factors in Women.
PubMed 文献 · J Clin Endocrinol Metab · 2016-07-26

这项队列研究纳入130例拟行减重手术的肥胖女性和35例非肥胖对照,检测血清及皮下白脂肪组织(Sc WAT)孵育液中的CCL18。结果显示,WAT可分泌CCL18,其水平与胰岛素抵抗、ATP III风险评分及血浆甘油三酯正相关,且不依赖体质指数;在80例肥胖女性中,胰岛素抵抗者的血清CCL18显著高于胰岛素敏感者。WAT中CCL18 mRNA表达于巨噬细胞,并与免疫相关基因尤其是M2巨噬细胞富集基因正相关;重组CCL18可增加M0/M2-THP-1细胞的细胞因子/趋化因子表达,但对人脂肪细胞体外无影响。作者认为CCL18可能构成WAT炎症的标志物。

要点

  • 肥胖女性WAT可分泌CCL18,其水平与胰岛素抵抗、ATP III风险评分和血浆甘油三酯正相关。
  • 在80例肥胖女性中,胰岛素抵抗者血清CCL18显著高于胰岛素敏感者。
  • WAT中CCL18 mRNA表达于巨噬细胞,并与免疫相关基因尤其M2巨噬细胞富集基因正相关。

核心结论

  • 循环及WAT分泌的CCL18与胰岛素抵抗和代谢风险评分相关,可能构成WAT炎症的标志物。

研究设计与样本

  • 队列研究,纳入130例拟行减重手术的肥胖女性和35例非肥胖对照,在门诊学术诊所开展。

主要发现

  • WAT可分泌CCL18,其水平与胰岛素抵抗、ATP III风险评分及血浆甘油三酯正相关,且独立于体质指数,相关性优于其他已知脂肪细胞因子。
  • 在80例肥胖女性中,胰岛素抵抗者的血清CCL18水平显著高于胰岛素敏感者。
  • WAT中CCL18 mRNA表达于巨噬细胞,并与免疫相关基因尤其M2巨噬细胞富集基因正相关。
  • 重组CCL18可增加M0/M2-THP-1细胞的细胞因子/趋化因子表达,但人脂肪细胞体外未见反应。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Cardiometabolic complications in obesity may be linked to white adipose tissue (WAT) dysfunction. Transcriptomic studies of Sc WAT have reported that CCL18, encoding the CC chemokine ligand 18 (CCL18), is increased in obesity/insulin resistance but its functional role is unknown. OBJECTIVE: Our objectives were to determine if CCL18 is secreted from Sc WAT and if secreted and/or serum levels associate with metabolic phenotypes. We also planned to define the primary cellular source and if CCL18 exerts effects on adipocytes. DESIGN: This is a cohort study. SETTING: The study took place in an outpatient academic clinic. PARTICIPANTS: A total of 130 obese women scheduled for bariatric surgery and 35 nonobese controls were included. METHODS: Insulin sensitivity was assessed by hyperinsulinemic euglycemic clamp or homeostasis model assessment. CCL18 was analyzed in serum/WAT incubates by ELISA. Effects of recombinant CCL18 was determined in cultures of primary human adipocytes and the monocyte cell line THP-1 differentiated into M0/M1/M2 macrophages. MAIN OUTCOME MEASURE: Association with metabolic risk factors was measured. RESULTS: CCL18 was secreted from WAT and the levels correlated positively with insulin resistance, Adult Treatment Panel III risk score and plasma triglycerides, independent of body mass index and better than other established adipocytokines. In 80 obese women, S-CCL18 levels were significantly higher in insulin resistant compared with insulin sensitive subjects. In WAT CCL18 mRNA was expressed in macrophages and correlated positively with immune-related genes, particularly those enriched in M2 macrophages. While CCL18 increased cyto-/chemokine expression in M0/M2-THP-1 cells, human adipocytes showed no responses in vitro. CONCLUSIONS: Circulating and WAT-secreted CCL18 correlates with insulin resistance and metabolic risk score. Because CCL18 is macrophage-specific and associates with adipose immune gene expression, it may constitute a marker of WAT inflammation.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Eriksson Hogling D, Petrus P, Gao H, et al. Adipose and Circulating CCL18 Levels Associate With Metabolic Risk Factors in Women. J Clin Endocrinol Metab. 2016. PMID: 27459538

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。